HealthLynked appoints Jeremy Daniel as part-time CFO; David Rosal resigns

HealthLynked Corp

Jeremy Daniel appointed CFO effective Jan 15, 2025; replaces David Rosal who resigned without disagreement.
Daniel works two days per week at $66K annual salary; also serves as CFO of Innoveren Scientific since 2019.
Daniel previously CFO at Regenerative Medicine Solutions (2013-19) and controller at Omnicare (2012-14).
Daniel holds MBA from Xavier University, BBA in Accounting from University of Cincinnati, and is a CPA.
CEO Michael Dent cited Daniel's experience in financial operations and strategic planning as key to appointment.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Jeremy Daniel

Chief Financial Officer

HLYK · HealthLynked Corp

Effective: 2025-01-15
Filed: January 15, 2025, 6:59 PM ET

Effective January 15, 2025, HealthLynked Corp., a Nevada corporation (the “ Company ”), appointed Jeremy Daniel, age 48, as its part-time Chief Financial Officer, effective immediately.

Departed

David Rosal

Chief Financial Officer

HLYK · HealthLynked Corp

Effective: 2025-01-15
Successor: Jeremy Daniel
Filed: January 15, 2025, 6:59 PM ET

Effective January 15, 2025, David Rosal tendered his resignation as Chief Financial Officer of the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Jeremy Daniel was appointed as Chief Financial Officer at HealthLynked Corp.

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

Effective January 15, 2025, HealthLynked Corp., a Nevada corporation (the “ Company ”), appointed Jeremy Daniel, age 48, as its part-time Chief Financial Officer, effective immediately.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

David Rosal resigned as Chief Financial Officer at HealthLynked Corp.

Action: resigned
Role: Chief Financial Officer

Exact text from the filing

Effective January 15, 2025, David Rosal tendered his resignation as Chief Financial Officer of the Company.

View on SEC.gov

HealthLynked Corp filing history →

Source: SEC EDGAR

accession 0001213900-25-003828

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.